Company Overview and News
Magotteaux’s pulp chemistry monitor made a big impression at the 2016 Prospect Awards, winning the Minerals Processing of the Year award. Magotteaux’s Dr Christopher Greet tells Australian Mining about how the technology has developed since.
Alicanto Minerals will retain 100 per cent ownership of the Arakaka gold project in Guyana, South America, following a decision taken by Barrick Gold to pull out of an earn-in agreement first established in March 2016 and last renewed in December last year. Barrick has spent over $US7.1 million ($9.6 million) on exploration since the inception of the joint venture (JV) between the two companies.
AQI ABX ABX
COEUR D'ALENE, ID / ACCESSWIRE / June 18, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") announced today that geologic mapping, surface sampling, and an aeromagnetic survey have defined a large porphyry copper target on the Elder Creek project in the Battle Mountain District of Nevada. Timberline has entered into a purchase and sale agreement with America's Gold Exploration Inc.
ABX MUX.RTWI MUX TLRS TLR MUX ABX
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- New Point Exploration Corp. (CSE:NP) (OTC:NPEZF) (Frankfurt:4NP) (“New Point” or the “Company”) is pleased to announce the addition of Senior Geologist, E.L. “Buster” Hunsaker, to the Board of Advisors. “I am very excited to welcome Buster to the Advisory Board for New Point,” commented Bryn Gardener-Evans, President & CEO. “Buster was integral to the recently announced Majuba Hill Copper Project acquisition — his knowledge of this project and other quality projects in the USA will bring enormous value to the company’s portfolio.
VGZ NPEZF ABX ABCO VGZ ABX
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AAI CATR ABX CAT NEM AA.PR AA.PRB AA NUE ABX
Futures are trading somewhat higher this morning, perhaps marking the apparent initial success of the summit that was held in Singapore between President Donald Trump and North Korean leader Kim Jong Un. Diplomacy aside, most of Wall Street is focused on the Federal Reserve meeting this week, and the potential for another increase in the federal funds rate.
SGEN MMYT DCP NEM IDCC MS.PRE PVA MS.PRF MS.PRG UFCS MS.PRA STML BPL SEAS MTCH MS ABX ABX FSB PVAYQ WTW BHLB EGRX MS.PRI MS.PRK PVAC FDC TRI SEMG ENBL SCOR
The historic summit between President Donald Trump and North Korea leader Kim Jong Un in Singapore has created history, possibly ending bitterness that lasted for 68 years. This is especially true as Trump and Kim signed an agreement, which offers undisclosed American “security guarantees” in exchange for a commitment from North Korea to “work toward complete denuclearization of the Korean Peninsula.
ABX NEM LULU TRI FITB SMLP FITBI ABX
COEUR D'ALENE, ID / ACCESSWIRE / June 12, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") announced today that results of surface rock chip sampling and geologic mapping have defined new, high-grade, gold exploration targets along the Oswego trend on its 23 square-mile Eureka property in Northern Nevada. The Oswego trend, which extends 5 km north-south, includes high-grade gold at the Road-Cut target, high-grade silver and gold at the Geddes- Bertrand target, and numerous additional untested targets.
ABX MUX.RTWI MUX TLRS TLR MUX ABX
Once again, gold stocks are struggling. The VanEck Vectors Gold Miners ETF (NYSEARCA:GDX) and the VanEck Vectors Junior Gold Miners ETF (NYSEARCA:GDJX) both have dropped about 13% from January highs. Both ETFs are down YTD as well — with performance lagging the S&P 500.
WPM TAHO FNV.WT.A ABX FNV AU K GDX SLW AULGF RGLD THO SLW KGC AGG IAG GG FNV RGL ABX GDXJ
TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:ABX)(TSX:ABX) (“Barrick” or the “Company”) has published its annual Sustainability Report, which provides a detailed and transparent look at the Company’s environmental and social performance over the past year. To view the report, please visit www.barrick.com.
Gold and gold miners have been all over the place this year. Often, we think of gold as a safe haven and defensive play, and often it is. But sometimes it’s in its own cycle or just another asset for people to sell in times of trouble. This year, gold is playing its role as a safe haven and is up 3% during a flat and tumultuous market. But for some reason, the miners are acting more like other stocks—and, at some periods, even worse than the market.
ABX KGC NEM K ABX
VANCOUVER, British Columbia, June 05, 2018 (GLOBE NEWSWIRE) -- Nevada Exploration Inc. (“NGE” or the “Company”) (TSX-V:NGE) (OTCQB:NVDEF) is pleased to report that the Company has significantly increased its land holdings at its Kelly Creek Project based on the results of its 2017 Scorpion drill program. With the addition of 153 new claims covering 1,090 ha, NGE now controls 5,320 ha in the Kelly Creek Basin, making it the third-largest holder in this important covered search space at the north end of the Cortez (Battle Mountain-Eureka) Trend, after Newmont Mining and Barrick Gold.
NVDEF ABX NGE NEM ABX
DAR ES SALAAM (Reuters) - Tanzania will issue large-scale mining licences only after cabinet approval, a senior official said on Friday, part of new measures aimed at further tightening control of the industry.
AULGF ABGLY ABX ABGLF ACA AU AGG ABX
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...
Silicon Investor Message Boards
This table lists all message boards related to TSX:ABX / Barrick Gold Corporation on message board site Silicon Investor.
|Barrick Gold (ABX)||Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG|
|Blue Chip Gold Stocks HM, NEM, ASA, ABX, PDG (MODERATED)||ABXA.ob ABX air former subsid Airborne|